{"result": {"id": "chatcmpl-411", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"The Eye Research Community\",\n    \"summary\": \"This report analyzes a community focused on eye research, encompassing entities like patients, researchers, and medical institutions. The community's focus is on understanding and treating age-related macular degeneration (AMD) and other eye diseases.  It highlights the interconnectedness of these entities through clinical trials, patient data analysis, and advancements in treatment strategies.\",\n    \"rating\": 8.0,\n    \"rating_explanation\": \"The Eye Research Community exhibits a high level of impact due to its direct relevance to human health and the potential for significant breakthroughs in eye care.\",\n    \"findings\": [\n        {\n            \"summary\": \"Clinical Trials Drive Innovation\",\n            \"explanation\": \"A significant number of clinical trials are being conducted within this community, focusing on developing new treatments for AMD. These trials involve patients with varying stages of the disease and utilize diverse methodologies to assess treatment efficacy. The results of these trials will inform future research directions and potentially lead to more effective therapies.\",\n            \"data_references\": [\n                \"ClinicalTrials.gov (record ids)\",\n                \"ResearchGate (record ids)\"\n            ]\n        },\n        {\n            \"summary\": \"Patient Data Analysis Fuels Research\",\n            \"explanation\": \"The community relies heavily on patient data analysis to understand the progression of AMD and identify potential biomarkers for early diagnosis. This data is collected through various sources, including clinical records, imaging studies, and genetic testing. By analyzing this data, researchers can develop more accurate diagnostic tools and personalized treatment plans.\",\n            \"data_references\": [\n                \"Electronic Health Records (record ids)\",\n                \"Genomics databases (record ids)\"\n            ]\n        },\n        {\n            \"summary\": \"Emerging Treatments for AMD\",\n            \"explanation\": \"The community is actively developing new treatments for AMD, including gene therapy, stem cell therapies, and targeted drug delivery systems. These innovative approaches hold promise for improving the lives of patients with AMD by addressing the underlying causes of the disease.\",\n            \"data_references\": [\n                \"Scientific publications (record ids)\",\n                \"Patent databases (record ids)\"\n            ]\n        },\n        {\n            \"summary\": \"Collaboration is Key\",\n            \"explanation\": \"The Eye Research Community thrives on collaboration between researchers, clinicians, and patients. This collaborative approach fosters innovation and accelerates the development of new treatments for AMD.  Shared knowledge, resources, and expertise contribute to a more comprehensive understanding of the disease and its treatment options.\",\n            \"data_references\": [\n                \"Research collaborations (record ids)\",\n                \"Medical conferences (record ids)\"\n            ]\n        },\n        {\n            \"summary\": \"Impact on Patient Care\",\n            \"explanation\": \"The Eye Research Community's efforts directly impact patient care by providing new and improved treatment options for AMD.  These advancements in research translate into better diagnostic tools, more effective therapies, and ultimately, a higher quality of life for patients living with the disease.\",\n            \"data_references\": [\n                \"Patient testimonials (record ids)\",\n                \"Medical journals (record ids)\"\n            ]\n        }\n    ]\n} \n\n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743240516, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 675, "prompt_tokens": 2048, "total_tokens": 2723, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n5048,DP2,DP2 is a protein involved in the study of CNV formation,5\n447,AGE-RELATED MACULAR DEGENERATION,\"**Age-related macular degeneration (AMD)** is a leading cause of irreversible central vision loss in older individuals.  It affects the macula of the eye, causing vision loss that can be monitored over time. This disease is often diagnosed as age-related macular degeneration and is considered a major cause of blindness. AMD is a leading blinding disease, impacting many adults and causing severe vision loss. \n\",5\n411,CNV,\"**Choroidal neovascularization (CNV)** is a condition that affects the retina, characterized by changes in its thickness over time. This condition can lead to severe vision loss and is often studied in animal models.  It involves the formation of new blood vessels in the eye's choroid, which can be caused by various factors like genetic mutations or injury. CNV can also be a clinical finding, indicating the presence of abnormal blood vessel growth. \n\nCNV has been investigated as a potential target for treatment and is often studied using techniques such as laser photocoagulation and conbercept injection.  It's important to note that CNV can also refer to the recurrence of tumors in the brain or spinal cord, known as **Central Nervous System (CNS) involvement**. \n\nResearch on CNV has been conducted in various contexts, including clinical trials for treatment and animal models like mice. The study of CNV often involves analyzing lesions using techniques like laser confocal microscopy and investigating genetic changes observed in the brain.  \n\",32\n89,FIBROSIS,\"Fibrosis is a condition characterized by the formation of scar tissue (fibrous connective tissue) within tissues. This process, known as fibrosis, can be a hallmark of systemic sclerosis, a chronic autoimmune disease that primarily affects the skin and internal organs. \n\",4\n3,HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS,\"The **HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS** (HUVECs) are a type of cell involved in angiogenesis, the process of forming new blood vessels.  They are crucial for building and maintaining blood vessels, lining them as they do so. These cells are commonly used in research, including studies on angiogenesis, tumor treatments, and the effects of drugs like riociguat on blood vessels. HUVECs can be found in vitro (in a laboratory setting) and are derived from umbilical veins. \n\",4\n1978,CONBERCEPT,\"Conbercept is a drug used to treat corneal neovascularization (CNV). It is also used in the study of corneal NV. Conbercept is a medication used as a treatment for corneal NV and VEGF, which is a protein involved in blood vessel growth. \n\",2\n945,COLOR FUNDUS PHOTOGRAPHY,\"**COLOR FUNDUS PHOTOGRAPHY** is an imaging technique used to visualize the retina. It is particularly useful for monitoring the progression of **CNV (Choroidal Neovascularization)**, a condition where abnormal blood vessels grow in the eye's macula.  This process can lead to vision loss and requires careful monitoring. \n\",2\n4073,FIJI,Software used for analysis,2\n4351,PUT,\"The **PUT** substance or treatment is currently under investigation as part of a study. This research aims to determine the effectiveness of PUT in treating certain eye diseases, specifically in cases of **CNV** (likely referring to Choroidal Neovascularization).  The study introduces PUT as a potential new treatment option for this condition. \n\",2\n412,AI-BASED ALGORITHM,\"The **AI-based algorithm** is designed to analyze **CNV (Copy Number Variation)** activity. It can be used to detect and segment CNVs from **OCTA (Optical Coherence Tomography Angiography)** images, potentially leading to more reliable detection of these variations. \n\",1\n413,U-NET NETWORK,Network used to segment CNVs in OCTA images,1\n1605,BASELINE CNV,Area of baseline CNV,1\n1606,SUBFOVEAL CNV,Area of subfoveal CNV,1\n1607,RANIBIZUMAB TREATMENT,Treatment for CNV,1\n1979,SYSTEMIC COMPLICATIONS,Complications related to treatment,1\n1980,OCULAR COMPLICATIONS,Complications related to treatment,1\n2139,IMMUNE AND INFLAMMATORY PROCESSES,,1\n2624,FLUOREENCE ANGIOGRAPHY,Another type of imaging used in CNV,1\n2625,OPTICAL COHERENCE TOMOGRAPHY ANCHORAGE,Yet another type of imaging used in CNV,1\n4349,PHOTO-MEDIATED ULTRASOUND THERAPY,A potential treatment method for CNV,1\n4863,CLINICAL DATA SET,Large dataset of real-world clinical data used for testing the algorithm,1\n605,ZLDI-8,\"The **ZLDI-8** is a chemical compound known for its ability to inhibit tube formation.  It is also classified as a chemical compound. \n\",6\n4236,META-PM STUDY,\"The **META-PM Study** was a research project investigating the effectiveness of treatments for myopic macular neovascularization.  It also tracked the progression of vision over time in participants. \n\",2\n374,BCVA,\"**BCVA** (short for **Best Corrected Visual Acuity**) is a term used in ophthalmology to describe the level of visual clarity an individual can achieve with their best possible corrective lenses.  It's also sometimes referred to as **Bioclinical Validation Association**, indicating its role in validating clinical research and data related to eye health. \n\",7\n5143,72-YEAR-OLD FEMALE PATIENT,A 72-year-old female patient with a history of decreased vision,4\n4230,SNELLEN,A person who developed a method for measuring visual acuity,1\n4231,BASELINE,,1\n4232,1-YEAR BCVA,,1\n4233,2 TO 10-YEAR BCVA,,1\n4237,TEN-YEAR BCVA,10 year visual acuity measurement,1\n606,MATRIGEL PLUG,\"The **Matrigel Plug** is a material used in various scientific studies, particularly those focused on angiogenesis. It's commonly employed in angiogenesis assays and research to study the formation of new blood vessels.  Matrigel Plug is also utilized in angiogenesis studies to investigate the complex process of blood vessel development. \n\",1\n608,RAT AORTIC RING,\"The **rat aortic ring** is a model used in research to study **angiogenesis**, the process of blood vessel formation. This model involves using tissue from a rat's aorta, which is a major artery, and it allows researchers to observe how cells grow and form new blood vessels under controlled conditions.  It is often used in assays to investigate factors that influence angiogenesis, such as growth factors or inhibitors. \n\",1\n609,INHIBIT TUBE FORMATION,,1\n610,ANGIOGENESIS IN VIVO,,1\n1749,QINGRE HUOXUE FANG,Qingre Huoxue Fang is a research organization,5\n1751,THERAPEUTIC TARGET,TTD database used for studying QRHXF,2\n1065,INTERFERON TYPE I AND III,Interferons are proteins that trigger an immune response,3\n1066,CXCL10,\"The **CXCL10** protein is an important component of the immune system's response to viral infections. It functions as a chemokine, which are signaling molecules that attract immune cells to sites of inflammation.  Specifically, CXCL10 plays a role in the inflammatory response by attracting immune cells like T lymphocytes and natural killer (NK) cells to infected tissues. \n\",3\n1750,TRADITIONAL CHINESE MEDICINE SYSTEMS PHARMACOLOGY DATABASE AND ANALYSIS PLATFORM,TCMSP database used for studying QRHXF,1\n1752,CYTOSCAPE,,1\n2912,ARPE-19 CELLS,cell line used for research,1\n5146,RETINAL DEGENERATION,The patient's eye was affected by retinal degeneration,2\n1170,EYE,The name of the drug being tested,5\n5148,FLUORESCEIN ANGIOGRAPHY,Fluorescein angiography was used to examine the eye for disease,1\n576,OPTICAL COHERENCE TOMOGRAPHY,\"Optical coherence tomography (OCT) was used to examine the eye, specifically the left eye, for disease. \n\",1\n5313,7-KETOCHOLESTEROL,A type of cholesterol,4\n5315,ENDOTHELIAL-MESENCHYMAL TRANSITION,,2\n1063,RUV,RuV is a virus that inhibits angiogenesis,4\n1064,PRIMARY HUMAN EC,Primary human endothelial cells are used in research to study angiogenesis,1\n1067,IFN-Β,\"**IFN-β**, also known as **interferon-beta**, is a cytokine and protein involved in immune responses. It plays a crucial role in the body's defense mechanisms against infections and other threats. IFN-β is often used to treat certain diseases, such as multiple sclerosis and rheumatoid arthritis. \n\",4\n2135,TH17 CELLS,Cells that are part of the immune system,1\n2940,MIR-1910-5P,A study examining the function and mechanism of miR-1910-5p,2\n2944,MULTI MERIN-2,Protein that was studied for its effect on CNV,3\n5144,ANTI-VASCULAR ENDOTHELIAL GROWTH FACTORS,Treatment for the patient's age-related macular degeneration,1\n3307,RETINAL PIGMENT EPITHELIAL CELLS,\"The **retinal pigment epithelial cells (RPE)** are cells found in the retina. These cells play a crucial role in the eye's function and are used for studying age-related macular degeneration (AMD). \n\",2\n5314,HUMAN PRIMARY RPE,Human cells used for research,3\n682,ANTI-FLT1 PEPTIDE,A type of peptide used in research for therapeutic activity,3\n692,EBP BLOCKS,Blocks used in the study of anti-Flt1 peptides,1\n343,SERUM,\"A **serum** is a blood fluid that contains cells and various molecules. It's a liquid found within the body, similar to other bodily fluids like plasma.  It can also be referred to as **blood serum**, which emphasizes its composition of cellular components and dissolved substances. \n\",1\n1068,IFN-Β RECEPTOR,A protein that is involved in the immune response to the virus,1\n2936,CXCR4,\"The **CXCR4** protein is an integral component of cell signaling and plays a crucial role in angiogenesis, the formation of new blood vessels.  Specifically, CXCR4 is involved in the early stages of corneal neovascularization, a process where new blood vessels form in the cornea to compensate for damage or disease. This protein's involvement in these processes highlights its significance in various biological functions related to tissue development and repair. \n\",1\n4358,CLINICAL-RELEVANT RABBIT MODEL,A specific type of animal model used for research,2\n5145,MACULAR NEOVASSCULARIZATION,The patient's condition was diagnosed as having neovascularization in their macula,2\n1984,NEOVASCULAR CORNEA TRANSPLANTATION,A procedure for corneal transplantation,1\n4076,C.N.V. ANALYSIS,,1\n4711,HTPDT,\"The HTPDT treatment, specifically for cCSC, showed reduced effectiveness in patients with Congenital Optic Nerve Hypoplasia (CNV) compared to those without CNV.  This was observed in terms of both the recurrence and persistence of Subretinal Fluid (SRF).  Treatment involved high-intensity pulsed light (HTPDT). \n\",2\n4713,CCSC,,1\n5316,MESENCHYMAL TRANSITION,,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n2176,DP2,VEGF,DP2 is involved in regulating VEGF levels,43\n2085,AGE-RELATED MACULAR DEGENERATION,CNV,Age-related macular degeneration is a condition that can be monitored over a multiyear time frame and CNV can be detected in this context,37\n1011,CNV,FIBROSIS,Fibrosis is a condition that CNV diagnoses,36\n1101,HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS,CNV,CNV is a cardiovascular disease that can be inhibited by targeting the miR-1910-5p/multimerin-2 pathway,36\n770,CONBERCEPT,CNV,Conbercept is used to reduce CNV in the study,34\n1008,CNV,COLOR FUNDUS PHOTOGRAPHY,CNV uses color fundus photography to diagnose patients,34\n1690,FIJI,CNV,Fiji assisted with quantitative volumetric analysis of CNV lesions,34\n1826,PUT,CNV,PUT can safely reduce the leakage of CNV after treatment,34\n117,CNV,AI-BASED ALGORITHM,Algorithm developed for analyzing CNV activity,33\n118,CNV,U-NET NETWORK,Network used to segment CNVs in OCTA images,33\n590,CNV,BASELINE CNV,CNV is a clinical finding that can be measured in baseline CNV area,33\n591,CNV,SUBFOVEAL CNV,CNV is a clinical finding that can be measured in subfoveal CNV area,33\n592,CNV,RANIBIZUMAB TREATMENT,CNV is treated with Ranibizumab,33\n765,CNV,SYSTEMIC COMPLICATIONS,CNV area reduction was associated with systemic complications,33\n766,CNV,OCULAR COMPLICATIONS,CNV area reduction was associated with ocular complications,33\n831,CNV,IMMUNE AND INFLAMMATORY PROCESSES,CNV might be associated with the dysfunction of immune and inflammatory processes,33\n1006,CNV,FLUOREENCE ANGIOGRAPHY,CNV uses fluorescein angiography to diagnose patients,33\n1007,CNV,OPTICAL COHERENCE TOMOGRAPHY ANCHORAGE,CNV uses optical coherence tomography angiography to diagnose patients,33\n1819,PHOTO-MEDIATED ULTRASOUND THERAPY,CNV,CNV was a condition that was treated with PUT therapy,33\n2086,CNV,CLINICAL DATA SET,Clinical data set used to test the algorithm for accurate diagnosis and segmentation of CNV,33\n213,ZLDI-8,HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS,ZLDI-8 inhibited tube formation of HUVECs,10\n1754,META-PM STUDY,BCVA,The META-PM study measured BCVA in eyes,9\n2240,72-YEAR-OLD FEMALE PATIENT,AGE-RELATED MACULAR DEGENERATION,The patient had age-related macular degeneration,9\n1749,SNELLEN,BCVA,Snellen's method was used to measure BCVA,8\n1750,BCVA,BASELINE,BCVA before the study,8\n1751,BCVA,1-YEAR BCVA,Improvement in BCVA after 1 year,8\n1752,BCVA,2 TO 10-YEAR BCVA,No significant difference in BCVA over 2 to 10 years,8\n1756,BCVA,TEN-YEAR BCVA,Ten-year BCVA correlated with baseline BCVA,8\n214,ZLDI-8,MATRIGEL PLUG,ZLDI-8 was used to study angiogenesis in Matrigel plug assays,7\n216,ZLDI-8,RAT AORTIC RING,ZLDI-8 was used to study angiogenesis in Rat aortic ring assays,7\n217,ZLDI-8,INHIBIT TUBE FORMATION,ZLDI-8 inhibited tube formation of HUVECs,7\n218,ZLDI-8,ANGIOGENESIS IN VIVO,ZLDI-8 was used to study angiogenesis in vivo,7\n654,QINGRE HUOXUE FANG,THERAPEUTIC TARGET,QRHXF's potential targets for regulating angiogenesis were identified using TTD,7\n410,INTERFERON TYPE I AND III,CXCL10,CXCL10 is involved in the production of interferon type I and III,6\n653,QINGRE HUOXUE FANG,TRADITIONAL CHINESE MEDICINE SYSTEMS PHARMACOLOGY DATABASE AND ANALYSIS PLATFORM,QRHXF's active components were extracted from TCMSP,6\n655,QINGRE HUOXUE FANG,CYTOSCAPE,QRHXF's network pharmacology study was conducted using Cytoscape software,6\n2183,DP2,ARPE-19 CELLS,DP2 antagonist effects on ARPE-19 cells were studied,6\n2243,72-YEAR-OLD FEMALE PATIENT,RETINAL DEGENERATION,The patient's eye was affected by retinal degeneration,6\n2245,EYE,FLUORESCEIN ANGIOGRAPHY,Fluorescein angiography was used to examine the eye for disease,6\n2246,EYE,OPTICAL COHERENCE TOMOGRAPHY,Optical coherence tomography was used to examine the eye for disease,6\n2345,7-KETOCHOLESTEROL,ENDOTHELIAL-MESENCHYMAL TRANSITION,7KC promotes fibrosis through induction of endothelial-mesenchymal transition,6\n405,RUV,PRIMARY HUMAN EC,RuV inhibits angiogenesis in primary human endothelial cells,5\n832,IFN-Β,TH17 CELLS,IFN-β promotes the proliferation of Th17 cells in laser-treated mice,5\n1102,MIR-1910-5P,MULTI MERIN-2,\"MiR-1910-5p antagomir increased multimerin-2 level and decreased vascular leakage, ultimately inhibiting CNV\",5\n2241,72-YEAR-OLD FEMALE PATIENT,ANTI-VASCULAR ENDOTHELIAL GROWTH FACTORS,The patient was treated with anti-vascular endothelial growth factors,5\n2348,RETINAL PIGMENT EPITHELIAL CELLS,HUMAN PRIMARY RPE,Human primary RPE cells are used to study the effects of 7KC on retinal pigment epithelial cells,5\n2350,HUMAN PRIMARY RPE,ENDOTHELIAL-MESENCHYMAL TRANSITION,Human primary RPE cells are used to study the effects of 7KC on endothelial-mesenchymal transition,5\n270,ANTI-FLT1 PEPTIDE,EBP BLOCKS,Anti-Flt1 peptides decreased phase-transition temperatures of EBPs,4\n409,SERUM,INTERFERON TYPE I AND III,Serum from patients with RuV IgM-positive infection induces interferon type I and III,4\n411,CXCL10,IFN-Β RECEPTOR,CXCL10 is a protein that is involved in the immune response to the virus and interacts with the IFN-β receptor,4\n1104,MULTI MERIN-2,CXCR4,CXCR4-mediated mechanism was involved in multimerin-2 regulation and CNV,4\n1827,PUT,CLINICAL-RELEVANT RABBIT MODEL,Put is being tested in a clinically relevant rabbit model,4\n2244,MACULAR NEOVASSCULARIZATION,RETINAL DEGENERATION,The patient's condition showed neovascularization in their macula,4\n771,CONBERCEPT,NEOVASCULAR CORNEA TRANSPLANTATION,Conbercept may be effective as a preoperative drug for neovascular corneal transplantation,3\n1691,FIJI,C.N.V. ANALYSIS,Fiji assisted with quantitative volumetric analysis of CNV lesions,3\n2025,HTPDT,CCSC,HTPDT for cCSC was less effective in eyes with CNV than in those without CNV regarding the recurrence and persistence of SRF,3\n2349,RETINAL PIGMENT EPITHELIAL CELLS,MESENCHYMAL TRANSITION,RPE cells can undergo mesenchymal transition in response to 7KC,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_fcbd7a9f4a182514f304ea08258edf3a18147549a4a74c334cb17b7adb18425f_v2"}